Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Twist Bioscience Corporation (TWST : NSDQ)

• Company Description    Twist Bioscience Corporation operates as a biotechnology company. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development and DNA as a digital data storage medium. Twist Bioscience Corporation is headquartered in San Francisco, California. Number of Employees: 979

• Price / Volume Information    Yesterday's Closing Price: $188.67 Daily Weekly Monthly 20 Day Moving Average: 2,262,462 shares Shares Outstanding: 62.71 (millions) Market Capitalization: $11,831.01 (millions) Beta: 2.19 52 Week High: $200.31 52 Week Low: $23.30 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 51.28% 51.19% 12 Week 108.17% 104.19% Year To Date 494.80% 427.23%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 681 GATEWAY BLVD - SOUTH SAN FRANCISCO,CA 94080 USA ph: 800-719-0671 fax: - abitting@twistbioscience.com http://www.twistbioscience.com

• General Corporate Information    Officers Emily M. Leproust - Chief Executive Officer and Chair of the Board of Adam Laponis - Chief Financial Officer Robert F. Werner - Chief Accounting Officer Nelson C. Chan - Director Robert Chess - Director Peer Information Twist Bioscience Corporation (CORR.) Twist Bioscience Corporation (RSPI) Twist Bioscience Corporation (CGXP) Twist Bioscience Corporation (BGEN) Twist Bioscience Corporation (GTBP) Twist Bioscience Corporation (RGRX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 90184D100 SIC: 2836 Fiscal Year Fiscal Year End: September Last Reported Quarter: 06/01/26 Next Expected EPS Date: 11/13/26 Share - Related Items Shares Outstanding: 62.71 Most Recent Split Date: (:1) Beta: 2.19 Market Capitalization: $11,831.01 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.39 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-1.56 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/13/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 26.54 Price/Cash Flow: - Price / Sales: 27.40 EPS Growth vs. Year Ago Period: -19.15% vs. Previous Quarter: 9.68% Sales Growth vs. Year Ago Period: 23.24% vs. Previous Quarter: 6.92% ROE 09/30/26 - - 06/30/26 - -28.64 03/31/26 - -26.73 ROA 09/30/26 - - 06/30/26 - -19.94 03/31/26 - -19.15 Current Ratio 09/30/26 - - 06/30/26 - 2.67 03/31/26 - 2.70 Quick Ratio 09/30/26 - - 06/30/26 - 2.38 03/31/26 - 2.42 Operating Margin 09/30/26 - - 06/30/26 - -30.34 03/31/26 - -30.39 Net Margin 09/30/26 - - 06/30/26 - -31.66 03/31/26 - -19.85 Pre-Tax Margin 09/30/26 - - 06/30/26 - -31.46 03/31/26 - -19.67 Book Value 09/30/26 - - 06/30/26 - 7.11 03/31/26 - 7.31 Inventory Turnover 09/30/26 - - 06/30/26 - 6.39 03/31/26 - 6.50 Debt-to-Equity 09/30/26 - - 06/30/26 - 0.03 03/31/26 - 0.03 Debt-to-Capital 09/30/26 - - 06/30/26 - 3.26 03/31/26 - 3.19

Powered by Zacks Investment Research ©